Careers  |  Sign In  |  Register

Latest in Hospitalist

Reuters Health • The Doctor's Channel Daily Newscast

Glycoprotein IIb/IIIa inhibitors still add benefit in elective PCI

NEW YORK (Reuters Health) - Even with routine use of stents and thienopyridines such as clopidogrel for elective percutaneous coronary intervention, glycoprotein IIb/IIIa inhibitors (GPIs) such as abciximab still provide additional benefit. That’s according to the findings of a meta-analysis reported...

Reuters Health • The Doctor's Channel Daily Newscast

Clopidogrel beneficial after revascularization by CABG following MI

NEW YORK (Reuters Health) – Clopidogrel improves outcomes not only in patients with myocardial infarction undergoing primary percutaneous coronary intervention, but also in MI patients revascularized by coronary artery bypass graft (CABG) surgery, a Danish team has shown. Their findings are reported in...

Reuters Health • The Doctor's Channel Daily Newscast

Combination ECG approach speedily spots emphysema

NEW YORK (Reuters Health) - Combining electrocardiographic P-axis and QRS duration data can provide enhanced criteria for emphysema detection, researchers report in a February 9th on-line paper in the American Journal of Cardiology. "With our criteria," David H. Spodick told Reuters Health by email,...